Clinical Trials Logo

Postmenopausal Disorder clinical trials

View clinical trials related to Postmenopausal Disorder.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06079528 Completed - Clinical trials for Stress Urinary Incontinence

Effect of Electromagnetic Stimulation Combined With Visceral Manipulation on Stress Urinary Incontinence In Postmenopausal Women

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

To examine the effect of electromagnetic stimulation combined with visceral manipulation on stress urinary incontinence in postmenopausal women

NCT ID: NCT06015919 Completed - Clinical trials for Postmenopausal Disorder

Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

Start date: December 5, 2022
Phase: N/A
Study type: Interventional

A study of effect of dash diet and acupuncture on hypertension in postmenopausal women

NCT ID: NCT05464654 Completed - Menopause Clinical Trials

Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause

VABIP
Start date: June 23, 2021
Phase: N/A
Study type: Interventional

The aim of the study was to compare the efficacy of vaginal biorevitalization to improve the genitourinary syndrome of menopause (GSM) between the gold-standard treatment with local estrogen-based hormone therapy versus local salmon polydeoxyribonucleotide (PDRN) therapy.

NCT ID: NCT05397015 Completed - Menopause Clinical Trials

Metabotyping in the Postmenopausal Stage

SHE-HEALTH
Start date: April 16, 2021
Phase:
Study type: Observational

Menopause is defined as the absence of menstrual periods for twelve consecutive months. Although the onset may vary, natural menopause occurs between the ages of 45 and 55 and is considered a stage in the aging process for women. Menopause is a stage strongly conditioned by hormonal modulations with effects on the cardiovascular system associated with abdominal obesity, insulin resistance, decreased energy expenditure, endothelial dysfunction, hypertension, and dyslipidemia. Furthermore, an increase in the production of proinflammatory cytokines involved in numerous pathologies such as osteoporosis has been observed. The results of several studies suggest that intestinal microbiota (IM) profile may be related to menopause condition by several means, although the data are stil inconclusive. Estrogen reduction leads to a progressive loss of bone density, a reduction in the bone formation/resorption balance and an increased risk of bone fractures among postmenopausal women. Recently, the alternative to estrogen therapies to reduce the risk of fractures are nutritional strategies fundamentally based on the use of probiotics, whose effect are associated with beneficial modulations of IM. SHE-HEALTH is a study in which, in a cohort of postmenopausal women, metabolomics, transcriptomics and metagenomics will be combined with the analysis of usual anthropometric and clinical biomarkers and also with genetic and epigenetic analyses to identify population groups (clusters). This study will allow establishing solid scientific bases to define, in future projects, effective nutritional strategies based on group nutrition in postmenopausal women. The main objective of the present study is to obtain clusters of postmenopausal women, identifying metabotypes (similar metabolic profiles) and enterotypes (similar IM profiles), and combining complementary variables such as classical anthropometric, biochemical and clinical biomarkers. The secondary objectives of the study are to characterize: 1) The genetic profile of the study cohort; 2) The epigenetic profile of the study cohort; 3) The gene expression profile of the study cohort.

NCT ID: NCT04701463 Completed - Obesity Clinical Trials

A Specialized Amino Acid Mixture on Body Composition and Skin State in Overweight and Obese Class I Postmenopausal Women

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

The use of dietary amino acids has been explored for therapeutic and safety intervention of obesity and obesity-induced dysfunction. In particular, 3 molecules have been shown to be effective both in the animal model and in humans, in promoting the loss of fat mass, specifically visceral adipose tissue, and in maintaining free fat mass: arginine, glutamine and leucine (and its metabolite beta hydroxy methyl butyrate, HMB). The aim of this study was to evaluate the efficacy in terms of fat mass, in particular Visceral Adipose Tissue reduction, as primary end point, in obese patients following the administration of specific food for special medical purposes (FSMP) for muscle recovery, consisting of arginine, glutamine and HMB. The secondary end point is the evaluation of skin state, by a validate self-reported questionnaire survey to assess skin, after 4- weeks intake of this FSMP.

NCT ID: NCT04492540 Completed - Cognitive Decline Clinical Trials

Response of Sex Hormones and Different Functions to Exercise and Diet in Elderly Women

Start date: December 20, 2020
Phase: N/A
Study type: Interventional

It is an interventional study in which 60 women estimated to enroll according to random allocation and divided into two groups. The study group will receive aerobic exercise in addition to diet restriction while the control group will receive diet recommendations. the aerobic exercise in form of treadmill training intensity of exercise moderate intensity, target heart rate (THR) will be 50-60% of heart maximum (HR MAX), time of session 40 min initial 10 min warm up exercise on treadmill in low intensity and active phase 20- 30 min intensity will increase until patient reach to THR then intensity decrease until session will be ended by cooling down phase for 10 min . The volunteers will perform exercise 3 times per week for 12 weeks .different functions and markers will be measured and sex hormones (estradiol ,testosterone. sex hormone binding globin ) pre and post

NCT ID: NCT04255992 Completed - Hypertension Clinical Trials

Short Term Cardiovascular Effects and Oxidative Status of Calcium and Vitamin D Supplementation of Postmenopausal Hypertensive Blacks Women

Start date: November 1, 2018
Phase: Phase 4
Study type: Interventional

This study aims to determine the effect of calcium and vitamin D supplementation on oxidative status and blood pressure profile of postmenopausal patients with high blood pressure in Yaoundé, Cameroon. This study is a double-arm, double-blind, randomized and parallel clinical trial conducted at the Yaoundé Central Hospital

NCT ID: NCT03295487 Completed - Clinical trials for Stress Urinary Incontinence

ToT and Estrogen in Postmenopausal Females

Start date: March 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

To compare the subjective and objective outcomes of TVT-O procedure alone versus the same procedure followed by the use of premarin vaginal cream for 3 months in postmenopausal female with genuine stress incontinence.

NCT ID: NCT03280693 Completed - Osteoporosis Clinical Trials

Relationships Among Body Mass Index, Body Balance and Bone Mineral Density in Postmenopausal Women

Start date: May 2015
Phase: N/A
Study type: Observational

Body composition, bone mineral density (BMD), and body balance are important factors that threaten postural control. They act as vital elements in the vicious circle that leads to fracture occurrence in elderly population, particularly postmenopausal women.

NCT ID: NCT03233932 Completed - Clinical trials for Postmenopausal Disorder

CKD-841 Pharmacokinetic/Pharmacodynamic Study

Start date: April 2016
Phase: Phase 1
Study type: Interventional

A randomized, open-label, single dose, parallel design phase I clinical trial to investigate the safety and pharmacokinetic/pharmacodynamics of CKD-841 or Leuplin Inj. 3.75mg after subcutaneous injection in postmenopausal female.